These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6257358)

  • 21. Rapid extraction of plasmids from Clostridium perfringens.
    Mahony DE; Clark GA; Stringer MF; MacDonald MC; Duchesne DR; Mader JA
    Appl Environ Microbiol; 1986 Mar; 51(3):521-3. PubMed ID: 2870680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of virulence plasmids among Clostridium perfringens type E isolates.
    Li J; Miyamoto K; McClane BA
    Infect Immun; 2007 Apr; 75(4):1811-9. PubMed ID: 17261608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The assessment and application of a bacteriocin typing scheme for Clostridium perfringens.
    Watson GN
    J Hyg (Lond); 1985 Feb; 94(1):69-79. PubMed ID: 2857743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcription activation of a UV-inducible Clostridium perfringens bacteriocin gene by a novel sigma factor.
    Dupuy B; Mani N; Katayama S; Sonenshein AL
    Mol Microbiol; 2005 Feb; 55(4):1196-206. PubMed ID: 15686564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of four plasmids from Bacillus subtilis.
    Tanaka T; Kuroda M; Sakaguchi K
    J Bacteriol; 1977 Mar; 129(3):1487-94. PubMed ID: 403179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Description of a bacteriocinogenic plasmid in Beneckea harveyi.
    McCall JO; Sizemore RK
    Appl Environ Microbiol; 1979 Nov; 38(5):974-9. PubMed ID: 317423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens.
    Garnier T; Cole ST
    Plasmid; 1988 Mar; 19(2):134-50. PubMed ID: 2901768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid copy number and stability determination in Clostridium perfringens transformants.
    Allen SP; Blaschek HP
    FEMS Microbiol Lett; 1990 Nov; 60(3):323-7. PubMed ID: 2083843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of transferable tetracycline resistance plasmids from Clostridium perfringens.
    Abraham LJ; Rood JI
    J Bacteriol; 1985 Feb; 161(2):636-40. PubMed ID: 2857166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of Clostridium perfringens and its L form to bacteriocins of C. perfringens.
    Mahony DE
    Can J Microbiol; 1982 Sep; 28(9):1032-6. PubMed ID: 6291734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of the etx gene (epsilon-toxin inducer) in plasmids of high molecular weight in Clostridium perfringens type D.
    Bentancor AB; Fermepín MR; Bentancor LD; de Torres RA
    FEMS Immunol Med Microbiol; 1999 Jul; 24(3):373-7. PubMed ID: 10397325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of two bacteriocins produced by Clostridium perfringens.
    Higa A; Yoshida E; Miyoshi Y
    Microbiol Immunol; 1991; 35(6):411-21. PubMed ID: 1921758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complete sequencing and diversity analysis of the enterotoxin-encoding plasmids in Clostridium perfringens type A non-food-borne human gastrointestinal disease isolates.
    Miyamoto K; Fisher DJ; Li J; Sayeed S; Akimoto S; McClane BA
    J Bacteriol; 2006 Feb; 188(4):1585-98. PubMed ID: 16452442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of UV-inducible promoters from Clostridium perfringens in vivo and in vitro.
    Garnier T; Cole ST
    Mol Microbiol; 1988 Sep; 2(5):607-14. PubMed ID: 2460717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5.
    Ersfeld-Dressen H; Sahl HG; Brandis H
    J Gen Microbiol; 1984 Nov; 130(11):3029-35. PubMed ID: 6527128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conjugation-Mediated Horizontal Gene Transfer of Clostridium perfringens Plasmids in the Chicken Gastrointestinal Tract Results in the Formation of New Virulent Strains.
    Lacey JA; Keyburn AL; Ford ME; Portela RW; Johanesen PA; Lyras D; Moore RJ
    Appl Environ Microbiol; 2017 Dec; 83(24):. PubMed ID: 29030439
    [No Abstract]   [Full Text] [Related]  

  • 37. The resolvase/invertase domain of the site-specific recombinase TnpX is functional and recognizes a target sequence that resembles the junction of the circular form of the Clostridium perfringens transposon Tn4451.
    Crellin PK; Rood JI
    J Bacteriol; 1997 Aug; 179(16):5148-56. PubMed ID: 9260958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that Tn5565, which includes the enterotoxin gene in Clostridium perfringens, can have a circular form which may be a transposition intermediate.
    Brynestad S; Granum PE
    FEMS Microbiol Lett; 1999 Jan; 170(1):281-6. PubMed ID: 9919679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a transferable tetracycline resistance plasmid (pCW3) from Clostridium perfringens.
    Rood JI; Scott VN; Duncan CL
    Plasmid; 1978 Sep; 1(4):563-70. PubMed ID: 219433
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors involved in the transformation of previously non-transformable Clostridium perfringens type B.
    Chen CK; Boucle CM; Blaschek HP
    FEMS Microbiol Lett; 1996 Jul; 140(2-3):185-91. PubMed ID: 8764481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.